Clinical research using the mesenchymal stem cells from autologous fat tissue of Alzheimer dementia - Regenerative medicine

OOYAMA TAKAYUKI0 sites3 target enrollmentAugust 9, 2019

Overview

No summary available.

Registry

who.int

Start Date

August 9, 2019

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

OOYAMA TAKAYUKI

•For the patients of this study, medical attendant doctor of the study should perform to take anamnesis and medical examination.
•The patients should be selected whom understood the purpose of this study and obtained to an agreement by documents during persons who has Alzheimer dementia, and adaptable to the guideline of diagnosis.
•The patients who acquired agreement of this study by free will of the person in a document, and age 40th to 88th, the sex do not matter.

•The patient corresponding to the following standards excludes from a targeted patient.
•1 The person that quantity of fat can't get enough for this study.
•2 The patient who is dialyzing.
•3 Pregnant patient.
•4 The person who medical attendant doctor decide not to appropriate from the viewpoint of safety, ethic and science.
•5 We need to confirm following anamnesis, and decide a competent judgement depending on having experience a blood transfusion or an organ transplantation.
•However, if we did not confirm an such anamnesis at the time of first judgement, we have to reconfirm when we finally become able to confirm such anamnesis later.
•1\) Infection with bacteria such as Treponema pallidum, a gonococcus, the tubercle bacillus
•2\)Sepsis and the doubt
•3\)Malignant tumor